SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare
CYBR 392.01+2.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sommovigo who wrote (2245)6/19/2000 3:18:00 PM
From: Kevin Podsiadlik  Read Replies (1) of 3392
 
Actually, the two issues, of approval, and pre-approval marketing, are not as linked as you seem to believe. It is my understanding, and I am going on experience with the SNRS case, that issues such as the question of CYBR's rule-breaking with pre-approval marketing are not allowed to be considered as factors in the approval process itself. If that is the case then approval is in no way vindication of CYBR's earlier activities.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext